NYSE:CYBN Cybin (CYBN) Stock Price, News & Analysis → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free CYBN Stock Alerts $0.29 0.00 (0.00%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$0.28▼$0.2950-Day Range N/A52-Week Range$0.25▼$0.74Volume5.50 million shsAverage Volume3.96 million shsMarket Capitalization$118.82 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsOwnershipSEC FilingsTrends Get Cybin alerts: Email Address Cybin MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1,628.9% Upside$5.00 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.21) to ($0.09) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.40 out of 5 starsMedical Sector733rd out of 914 stocksPharmaceutical Preparations Industry343rd out of 429 stocks 3.5 Analyst's Opinion Consensus RatingCybin has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageCybin has only been the subject of 1 research reports in the past 90 days.Read more about Cybin's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for CYBN. Previous Next 0.0 Dividend Strength Dividend YieldCybin does not currently pay a dividend.Dividend GrowthCybin does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CYBN. Previous Next 2.5 News and Social Media Coverage News SentimentCybin has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.91 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Cybin this week, compared to 1 article on an average week.Search Interest14 people have searched for CYBN on MarketBeat in the last 30 days. This is an increase of 56% compared to the previous 30 days.MarketBeat Follows22 people have added Cybin to their MarketBeat watchlist in the last 30 days. This is an increase of 16% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cybin insiders have not sold or bought any company stock.Percentage Held by Insiders15.00% of the stock of Cybin is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 17.94% of the stock of Cybin is held by institutions.Read more about Cybin's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Cybin are expected to grow in the coming year, from ($0.21) to ($0.09) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cybin is -1.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cybin is -1.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCybin has a P/B Ratio of 1.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Gold Safe ExchangeGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing demand from Central Banks and billionaires to EXPLODE! The elites are buying up gold like nothing we've seen before… Click here now to download the free Precious Metals Buying Guide. About CybinCybin Inc. is a biotechnology company. It is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. Cybin Inc. is based in Toronto, Canada.Read More CYBN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CYBN Stock News HeadlinesJune 11, 2024 | businesswire.comCybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical DevelopmentMay 29, 2024 | businesswire.comCybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024May 14, 2024 | businesswire.comCybin to Participate in the Alliance Global Partners Healthcare Company ShowcaseSee More Headlines Receive CYBN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cybin and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/16/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNYSE:CYBN CUSIPN/A CIK1833141 Webwww.cybin.com Phone908-764-8385FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$5.00 High Stock Price Target$5.00 Low Stock Price Target$5.00 Potential Upside/Downside+1,628.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-35,930,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-109.05% Return on Assets-97.85% Debt Debt-to-Equity RatioN/A Current Ratio5.76 Quick Ratio5.76 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.19 per share Price / Book1.52Miscellaneous Outstanding Shares410,860,000Free Float349,227,000Market Cap$118.82 million OptionableN/A Beta0.50 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key CompetitorsCOMPASS PathwaysNASDAQ:CMPSVerve TherapeuticsNASDAQ:VERVAltimmuneNASDAQ:ALTIGM BiosciencesNASDAQ:IGMSAC ImmuneNASDAQ:ACIUView All CompetitorsInstitutional OwnershipRA Capital Management L.P.Bought 58,139,535 shares on 5/17/2024Ownership: 14.151%Ikarian Capital LLCBought 13,953,488 shares on 5/17/2024Ownership: 3.396%AWM Investment Company Inc.Bought 2,250,000 shares on 5/16/2024Ownership: 0.548%PEAK6 Investments LLCBought 228,716 shares on 5/15/2024Ownership: 0.056%View All Institutional Transactions CYBN Stock Analysis - Frequently Asked Questions Should I buy or sell Cybin stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cybin in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CYBN shares. View CYBN analyst ratings or view top-rated stocks. What is Cybin's stock price target for 2024? 1 equities research analysts have issued 1-year target prices for Cybin's shares. Their CYBN share price targets range from $5.00 to $5.00. On average, they expect the company's share price to reach $5.00 in the next twelve months. This suggests a possible upside of 1,628.9% from the stock's current price. View analysts price targets for CYBN or view top-rated stocks among Wall Street analysts. How have CYBN shares performed in 2024? Cybin's stock was trading at $0.35 on January 1st, 2024. Since then, CYBN stock has decreased by 17.4% and is now trading at $0.2892. View the best growth stocks for 2024 here. What ETF holds Cybin's stock? Simplify Propel Opportunities ETF holds 500,000 shares of CYBN stock, representing 0.18% of its portfolio. Who are Cybin's major shareholders? Cybin's stock is owned by a variety of retail and institutional investors. Top institutional investors include RA Capital Management L.P. (14.15%), Ikarian Capital LLC (3.40%), AWM Investment Company Inc. (0.55%) and PEAK6 Investments LLC (0.06%). How do I buy shares of Cybin? Shares of CYBN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:CYBN) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cybin Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cybin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.